Increased incidence of disseminated histoplasmosis following highly active antiretroviral therapy initiation.
about
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerHIV-associated histoplasmosis early mortality and incidence trends: from neglect to priority.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theGranulomatous hepatitis secondary to histoplasma infection after treatment with infliximab.Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy erasDisseminated histoplasmosis with oral manifestation.Risk factors for disseminated histoplasmosis in a cohort of HIV-infected patients in French Guiana.Antigen negative gastrointestinal histoplasmosis in an AIDS patientUnmasking histoplasmosis immune reconstitution inflammatory syndrome in a patient recently started on antiretroviral therapy.Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case report and literature review.Disseminated histoplasmosis in HIV-infected patients: determinants of relapse and mortality in a north-eastern area of Brazil.Involvement of intraocular structures in disseminated histoplasmosis.AIDS-Related Endemic Mycoses in Western Cape, South Africa, and Clinical Mimics: A Cross-Sectional Study of Adults With Advanced HIV and Recent-Onset, Widespread Skin Lesions.
P2860
Q33650105-4099055F-C28B-4A7D-8381-2E468C25F127Q34075154-5AC100E9-745F-45D3-B31E-CB7980107ABDQ34212799-966BD91D-5D54-4ED3-AE82-34F2B19C63DEQ34399044-941C1826-DC7B-42E7-B63D-7815C4E8FAFFQ35494596-690BA698-1820-4499-95D1-54531797AEADQ37236282-8397410B-A5FD-4295-A9E8-C0BD6F364B3AQ37533899-093D919D-2E24-4C6A-AF37-207AA1A54688Q37619670-60F90735-CC45-407B-91EF-95C308F9235BQ37638380-F412DA22-E368-4878-B0EC-23B7C1A0378CQ38195802-A1509577-DC8C-473B-8876-3B744BA9619EQ42224893-C31F0DFA-BAE4-4352-A5EE-2F463D580293Q46164848-F797166A-114D-489D-8D40-F0AEC8D9DC4FQ46256434-73D8DC9A-504A-45BF-B39D-344A7E18A61E
P2860
Increased incidence of disseminated histoplasmosis following highly active antiretroviral therapy initiation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Increased incidence of dissemi ...... retroviral therapy initiation.
@en
Increased incidence of dissemi ...... retroviral therapy initiation.
@nl
type
label
Increased incidence of dissemi ...... retroviral therapy initiation.
@en
Increased incidence of dissemi ...... retroviral therapy initiation.
@nl
prefLabel
Increased incidence of dissemi ...... retroviral therapy initiation.
@en
Increased incidence of dissemi ...... retroviral therapy initiation.
@nl
P2093
P1476
Increased incidence of dissemi ...... iretroviral therapy initiation
@en
P2093
Andry Randrianjohany
Bernard Carme
Christine Aznar
Fernand Alvarez
Frédérique Sarazin
Mathieu Nacher
Myriam El Guedj
Valery Nasser
P304
P356
10.1097/01.QAI.0000209927.49656.8D
P407
P577
2006-04-01T00:00:00Z